These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 35815441)

  • 1. Blood biomarkers for canine cancer, from human to veterinary oncology.
    Colombe P; Béguin J; Benchekroun G; Le Roux D
    Vet Comp Oncol; 2022 Dec; 20(4):767-777. PubMed ID: 35815441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDC6: A novel canine tumour biomarker detected in circulating extracellular vesicles.
    Andriessen A; Bongiovanni L; Driedonks TAP; van Liere E; Seijger A; Hegeman CV; van Nimwegen SA; Galac S; Westendorp B; Nolte-'t Hoen ENM; de Bruin A
    Vet Comp Oncol; 2022 Jun; 20(2):381-392. PubMed ID: 34743398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Noninvasive Diagnostics.
    Wiley C; Wise CF; Breen M
    Vet Clin North Am Small Anim Pract; 2019 Sep; 49(5):781-791. PubMed ID: 31280902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive Blood-Based Cancer Detection in Veterinary Medicine.
    Flory A; Wilson-Robles H
    Vet Clin North Am Small Anim Pract; 2024 May; 54(3):541-558. PubMed ID: 38195361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response evaluation criteria for solid tumours in dogs (v1.0): a Veterinary Cooperative Oncology Group (VCOG) consensus document.
    Nguyen SM; Thamm DH; Vail DM; London CA
    Vet Comp Oncol; 2015 Sep; 13(3):176-83. PubMed ID: 23534501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic and predictive markers in canine tumours: rationale and relevance. A review.
    Mukaratirwa S
    Vet Q; 2005 Jun; 27(2):52-64. PubMed ID: 16022341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The application of circulating tumor cells detecting methods in veterinary oncology.
    Chmielewska M; Łosiewicz K; Socha P; Mecik-Kronenberg T; Wasowicz K
    Pol J Vet Sci; 2013; 16(1):141-51. PubMed ID: 23691590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic analysis across 53 canine cancer types reveals novel mutations and high clinical actionability potential.
    Sakthikumar S; Warrier M; Whitley D; Facista S; Adkins J; Aman S; Tsinajinnie D; Duran N; Siravegna G; Ahmed Z; Day K; Jenkins B; Patel N; Ryden K; Nadai J; Banovich K; Powers B; Edwards J; Steinberg J; Fielder S; Wong S; Byron SA; Izatt T; Zismann V; Boateng M; Zhu Z; Chuang HY; Trent JM; Haworth D; Chon E; Hendricks W; Wang G
    Vet Comp Oncol; 2024 Mar; 22(1):30-41. PubMed ID: 38053317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased plasma DR-70 (fibrinogen-fibrin degradation products) concentrations as a diagnostic biomarker in dogs with neoplasms.
    Ke CH; Sio KM; Wu CH; Xia YY; Lee JJ; Hu CH; Liu CC; Lu CL; Cheng CL; Lin KH; Tomiyasu H; Wang YS; Lin CS
    J Vet Intern Med; 2023; 37(6):2391-2401. PubMed ID: 37837297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canine paediatric oncology: retrospective assessment of 9522 tumours in dogs up to 12 months (1993-2008).
    Schmidt JM; North SM; Freeman KP; Ramiro-Ibañez F
    Vet Comp Oncol; 2010 Dec; 8(4):283-92. PubMed ID: 21062410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer detection in clinical practice and using blood-based liquid biopsy: A retrospective audit of over 350 dogs.
    Flory A; McLennan L; Peet B; Kroll M; Stuart D; Brown D; Stuebner K; Phillips B; Coomber BL; Woods JP; Miller M; Tripp CD; Wolf-Ringwall A; Kruglyak KM; McCleary-Wheeler AL; Phelps-Dunn A; Wong LK; Warren CD; Brandstetter G; Rosentel MC; DiMarzio LR; O'Kell AL; Cohen TA; Grosu DS; Chibuk J; Tsui DWY; Chorny I; Rafalko JM
    J Vet Intern Med; 2023 Jan; 37(1):258-267. PubMed ID: 36661398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relevance of liquid biopsy in surgical oncology: The application of perioperative circulating nucleic acid dynamics in improving patient outcomes.
    Jordan PR; O'Leary DP; Fleming CA; Wang J; Redmond HP
    Surgeon; 2022 Aug; 20(4):e163-e173. PubMed ID: 34362650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of plasma cell-free DNA levels in dogs with various tumors.
    Tagawa M; Shimbo G; Inokuma H; Miyahara K
    J Vet Diagn Invest; 2019 Nov; 31(6):836-843. PubMed ID: 31585514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic and proteomic profiling for cancer diagnosis in dogs.
    Morris JS
    Vet J; 2016 Sep; 215():101-9. PubMed ID: 26848120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum thymidine kinase 1 and C-reactive protein as biomarkers for screening clinically healthy dogs for occult disease.
    Selting KA; Sharp CR; Ringold R; Knouse J
    Vet Comp Oncol; 2015 Dec; 13(4):373-84. PubMed ID: 23859156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer antigen 15/3: possible diagnostic use in veterinary clinical oncology. Preliminary study.
    Marchesi MC; Manuali E; Pacifico E; Ferri C; Romagnoli M; Mangili V; Fruganti G
    Vet Res Commun; 2010 Jun; 34 Suppl 1():S103-6. PubMed ID: 20432064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid biopsy can detect BRCA2 gene variants in female dogs with mammary neoplasia.
    de Oliveira JR; Colombo J; Gonçalves FM; de Carvalho LAL; Costa DS; Henrique T; Novais AA; Moschetta-Pinheiro MG; Chuffa LGA; Coutinho LL; Santana ÁE; Zuccari DAPC
    Vet Comp Oncol; 2022 Mar; 20(1):164-171. PubMed ID: 34328705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma.
    Trevisan França de Lima L; Broszczak D; Zhang X; Bridle K; Crawford D; Punyadeera C
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188451. PubMed ID: 33065194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precision Medicine in Veterinary Science.
    Chon E; Hendricks W; White M; Rodrigues L; Haworth D; Post G
    Vet Clin North Am Small Anim Pract; 2024 May; 54(3):501-521. PubMed ID: 38212188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating microRNA-214 and -126 as potential biomarkers for canine neoplastic disease.
    Heishima K; Ichikawa Y; Yoshida K; Iwasaki R; Sakai H; Nakagawa T; Tanaka Y; Hoshino Y; Okamura Y; Murakami M; Maruo K; Akao Y; Mori T
    Sci Rep; 2017 May; 7(1):2301. PubMed ID: 28536479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.